Methylene blue - Generic Drug Details
✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
What are the generic drug sources for methylene blue and what is the scope of patent protection?
Methylene blueis the generic ingredient in one branded drug marketed by Provepharm Sas and is included in one NDA. Additional information is available in the individual branded drug profile pages.
There are four drug master file entries for methylene blue. One supplier is listed for this compound.
Summary for methylene blue
|Drug Master File Entries:||4|
|Finished Product Suppliers / Packagers:||1|
|Raw Ingredient (Bulk) Api Vendors:||121|
|Formulation / Manufacturing:||see details|
|What excipients (inactive ingredients) are in methylene blue?||methylene blue excipients list|
|DailyMed Link:||methylene blue at DailyMed|
Recent Clinical Trials for methylene blue
Identify potential brand extensions & 505(b)(2) entrants
|Nanjing First Hospital, Nanjing Medical University||Phase 3|
|Hugh Taylor||Early Phase 1|
|Multidisciplinary Association for Psychedelic Studies||Phase 1|
Pharmacology for methylene blue
|Drug Class||Oxidation-Reduction Agent|
|Mechanism of Action||Oxidation-Reduction Activity|
Medical Subject Heading (MeSH) Categories for methylene blue
US Patents and Regulatory Information for methylene blue
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Provepharm Sas||PROVAYBLUE||methylene blue||SOLUTION;INTRAVENOUS||204630-002||Jul 18, 2019||RX||Yes||Yes||See Plans and Pricing||See Plans and Pricing||See Plans and Pricing|
|Provepharm Sas||PROVAYBLUE||methylene blue||SOLUTION;INTRAVENOUS||204630-001||Apr 8, 2016||RX||Yes||Yes||See Plans and Pricing||See Plans and Pricing||See Plans and Pricing|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.